A new trading day began on Friday, with Immuneering Corp (NASDAQ: IMRX) stock price down -7.35% from the previous day of trading, before settling in for the closing price of $6.53. IMRX’s price has ranged from $1.10 to $10.08 over the past 52 weeks.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -46.45%. Meanwhile, its annual earnings per share averaged 21.47%. With a float of $43.31 million, this company’s outstanding shares have now reached $60.53 million.
Immuneering Corp (IMRX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Immuneering Corp is 28.41%, while institutional ownership is 6.33%. The most recent insider transaction that took place on Oct 01 ’25, was worth 1,917. In this transaction Chief Accounting Officer of this company bought 300 shares at a rate of $6.39, taking the stock ownership to the 27,533 shares. Before that another transaction happened on Oct 01 ’25, when Company’s CHIEF PEOPLE OFFICER bought 800 for $6.38, making the entire transaction worth $5,103. This insider now owns 23,344 shares in total.
Immuneering Corp (IMRX) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.49 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 21.47% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.07% during the next five years compared to -46.45% drop over the previous five years of trading.
Immuneering Corp (NASDAQ: IMRX) Trading Performance Indicators
Here are Immuneering Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.90, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -1.90 in one year’s time.
Technical Analysis of Immuneering Corp (IMRX)
Compared to the last year’s volume of 1.47 million, its volume of 3.98 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 2.83%.
During the past 100 days, Immuneering Corp’s (IMRX) raw stochastic average was set at 54.74%, which indicates a significant increase from 0.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.99 in the past 14 days, which was higher than the 0.49 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.64, while its 200-day Moving Average is $2.94. Nevertheless, the first resistance level for the watch stands at $6.66 in the near term. At $7.27, the stock is likely to face the second major resistance level. The third major resistance level sits at $7.59. If the price goes on to break the first support level at $5.73, it is likely to go to the next support level at $5.41. Now, if the price goes above the second support level, the third support stands at $4.80.
Immuneering Corp (NASDAQ: IMRX) Key Stats
With a market capitalization of 366.21 million, the company has a total of 41,570K Shares Outstanding. Currently, annual sales are 0 K while annual income is -61,040 K. The company’s previous quarter sales were 0 K while its latest quarter income was -14,430 K.
